Search

Search Constraints

You searched for: Author/Creator Ibrahim, Ramy

Search Results

1. A phase 2 randomized, double-blind, placebo-controlled study of tremelimumab for second and third line treatment in patients with unresectable pleural or peritoneal mesothelioma. (7th November 2013)

2. CD40 agonistic monoclonal antibody APX005M (sotigalimab) and chemotherapy, with or without nivolumab, for the treatment of metastatic pancreatic adenocarcinoma: an open-label, multicentre, phase 1b study. Issue 1 (January 2021)

3. Differences According to Sex in Perspectives and Beliefs on Osteoporosis: A Cross‐Sectional Survey Study. Issue 10 (30th September 2016)

4. Do Sociodemographic Factors Influence Outcome in Prostate Cancer Patients Treated With External Beam Radiation Therapy?. (December 2016)

5. Future cancer research priorities in the USA: a Lancet Oncology Commission. Issue 11 (November 2017)

8. Ipilimumab alone or in combination with nivolumab in patients with advanced melanoma who have progressed or relapsed on PD-1 blockade: clinical outcomes and translational biomarker analyses. Issue 1 (24th January 2022)

10. Neoadjuvant immunotherapy is reshaping cancer management across multiple tumour types: The future is now!. (July 2021)